Cargando…

Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study

BACKGROUND: Obesity is an important cause of multiple cancer types, amongst which endometrial cancer (EC). The relation between obesity and cancer is complicated and involves alterations in insulin metabolism, response to inflammation and alterations in estradiol metabolism. Visceral obesity is assu...

Descripción completa

Detalles Bibliográficos
Autores principales: van Weelden, Willem Jan, Fasmer, Kristine Eldevik, Tangen, Ingvild L., IntHout, Joanna, Abbink, Karin, van Herwaarden, Antionius E., Krakstad, Camilla, Massuger, Leon F. A. G., Haldorsen, Ingfrid S., Pijnenborg, Johanna M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555924/
https://www.ncbi.nlm.nih.gov/pubmed/31174495
http://dx.doi.org/10.1186/s12885-019-5770-6
_version_ 1783425236657504256
author van Weelden, Willem Jan
Fasmer, Kristine Eldevik
Tangen, Ingvild L.
IntHout, Joanna
Abbink, Karin
van Herwaarden, Antionius E.
Krakstad, Camilla
Massuger, Leon F. A. G.
Haldorsen, Ingfrid S.
Pijnenborg, Johanna M. A.
author_facet van Weelden, Willem Jan
Fasmer, Kristine Eldevik
Tangen, Ingvild L.
IntHout, Joanna
Abbink, Karin
van Herwaarden, Antionius E.
Krakstad, Camilla
Massuger, Leon F. A. G.
Haldorsen, Ingfrid S.
Pijnenborg, Johanna M. A.
author_sort van Weelden, Willem Jan
collection PubMed
description BACKGROUND: Obesity is an important cause of multiple cancer types, amongst which endometrial cancer (EC). The relation between obesity and cancer is complicated and involves alterations in insulin metabolism, response to inflammation and alterations in estradiol metabolism. Visceral obesity is assumed to play the most important role in the first two mechanisms, but its role in estradiol metabolism is unclear. Therefore, this retrospective study explores the relationship of body mass index (BMI), visceral fat volume (VAV) and subcutaneous fat volume (SAV) and serum levels of sex steroids and lipids in patients with endometrial cancer. METHODS: Thirty-nine postmenopausal EC patients with available BMI, blood serum and Computed Tomography (CT) scans were included. Serum was analyzed for estradiol, dehydroepiandrosterone sulfate (DHEAS), androstenedione, testosterone, cholesterol, triglycerides and high (HDL), low (LDL) and non-high density (NHDL) lipoprotein. VAV and SAV were quantified on abdominal CT scan images. Findings were interpreted using pearson correlation coefficient and linear regression with commonality analysis. RESULTS: Serum estradiol is moderately correlated with BMI (r = 0.62) and VAV (r = 0.58) and strongly correlated with SAV (r = 0.74) (p < 0.001 for all). SAV contributes more to estradiol levels than VAV (10.3% for SAV, 1.4% for VAV, 35.9% for SAV and VAV, p = 0.01). Other sex steroids and lipids have weak and moderate correlations with VAV or SAV. CONCLUSIONS: This study shows that serum estradiol is correlated with BMI and other fat-distribution measures in postmenopausal endometrial cancer patients. Subcutaneous fat tissue contributes more to the estradiol levels indicating that subcutaneous fat might be relevant in endometrial cancer carcinogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-5770-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6555924
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65559242019-06-10 Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study van Weelden, Willem Jan Fasmer, Kristine Eldevik Tangen, Ingvild L. IntHout, Joanna Abbink, Karin van Herwaarden, Antionius E. Krakstad, Camilla Massuger, Leon F. A. G. Haldorsen, Ingfrid S. Pijnenborg, Johanna M. A. BMC Cancer Research Article BACKGROUND: Obesity is an important cause of multiple cancer types, amongst which endometrial cancer (EC). The relation between obesity and cancer is complicated and involves alterations in insulin metabolism, response to inflammation and alterations in estradiol metabolism. Visceral obesity is assumed to play the most important role in the first two mechanisms, but its role in estradiol metabolism is unclear. Therefore, this retrospective study explores the relationship of body mass index (BMI), visceral fat volume (VAV) and subcutaneous fat volume (SAV) and serum levels of sex steroids and lipids in patients with endometrial cancer. METHODS: Thirty-nine postmenopausal EC patients with available BMI, blood serum and Computed Tomography (CT) scans were included. Serum was analyzed for estradiol, dehydroepiandrosterone sulfate (DHEAS), androstenedione, testosterone, cholesterol, triglycerides and high (HDL), low (LDL) and non-high density (NHDL) lipoprotein. VAV and SAV were quantified on abdominal CT scan images. Findings were interpreted using pearson correlation coefficient and linear regression with commonality analysis. RESULTS: Serum estradiol is moderately correlated with BMI (r = 0.62) and VAV (r = 0.58) and strongly correlated with SAV (r = 0.74) (p < 0.001 for all). SAV contributes more to estradiol levels than VAV (10.3% for SAV, 1.4% for VAV, 35.9% for SAV and VAV, p = 0.01). Other sex steroids and lipids have weak and moderate correlations with VAV or SAV. CONCLUSIONS: This study shows that serum estradiol is correlated with BMI and other fat-distribution measures in postmenopausal endometrial cancer patients. Subcutaneous fat tissue contributes more to the estradiol levels indicating that subcutaneous fat might be relevant in endometrial cancer carcinogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-5770-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-06-07 /pmc/articles/PMC6555924/ /pubmed/31174495 http://dx.doi.org/10.1186/s12885-019-5770-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
van Weelden, Willem Jan
Fasmer, Kristine Eldevik
Tangen, Ingvild L.
IntHout, Joanna
Abbink, Karin
van Herwaarden, Antionius E.
Krakstad, Camilla
Massuger, Leon F. A. G.
Haldorsen, Ingfrid S.
Pijnenborg, Johanna M. A.
Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
title Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
title_full Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
title_fullStr Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
title_full_unstemmed Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
title_short Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
title_sort impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555924/
https://www.ncbi.nlm.nih.gov/pubmed/31174495
http://dx.doi.org/10.1186/s12885-019-5770-6
work_keys_str_mv AT vanweeldenwillemjan impactofbodymassindexandfatdistributiononsexsteroidlevelsinendometrialcarcinomaaretrospectivestudy
AT fasmerkristineeldevik impactofbodymassindexandfatdistributiononsexsteroidlevelsinendometrialcarcinomaaretrospectivestudy
AT tangeningvildl impactofbodymassindexandfatdistributiononsexsteroidlevelsinendometrialcarcinomaaretrospectivestudy
AT inthoutjoanna impactofbodymassindexandfatdistributiononsexsteroidlevelsinendometrialcarcinomaaretrospectivestudy
AT abbinkkarin impactofbodymassindexandfatdistributiononsexsteroidlevelsinendometrialcarcinomaaretrospectivestudy
AT vanherwaardenantioniuse impactofbodymassindexandfatdistributiononsexsteroidlevelsinendometrialcarcinomaaretrospectivestudy
AT krakstadcamilla impactofbodymassindexandfatdistributiononsexsteroidlevelsinendometrialcarcinomaaretrospectivestudy
AT massugerleonfag impactofbodymassindexandfatdistributiononsexsteroidlevelsinendometrialcarcinomaaretrospectivestudy
AT haldorseningfrids impactofbodymassindexandfatdistributiononsexsteroidlevelsinendometrialcarcinomaaretrospectivestudy
AT pijnenborgjohannama impactofbodymassindexandfatdistributiononsexsteroidlevelsinendometrialcarcinomaaretrospectivestudy